Annals of Surgical Oncology

, Volume 26, Issue 11, pp 3489–3494 | Cite as

Practitioner Opinion on Contralateral Prophylactic Mastectomy: How Do We Steer a Patient-Driven Discussion?

  • Angela E. Schellenberg
  • Amanda Stypulkowski
  • Erin Cordeiro
  • Claire M. B. Holloway
  • Andrea Eisen
  • Adena S. ScheerEmail author
Breast Oncology



Contralateral prophylactic mastectomy (CPM) is increasing despite a recent statement from The American Society of Breast Surgeons discouraging average-risk women with unilateral breast cancer (BC) from undergoing CPM. The objective of our study was to conduct a needs assessment of BC health practitioners to gather information about their opinions, attitudes, and experiences surrounding CPM.


The Ottawa Decision Support Framework was the theoretical framework for the development of the interview guide. Semistructured interviews were conducted until data saturation with a convenience sample of 16 BC practitioners (Ontario, Canada), including oncologic and reconstructive surgeons, medical oncologists, and nurse navigators.


Nearly all practitioners identified the discussion regarding CPM as patient-initiated. The majority of practitioners (13/16) described their role as supporting the patient in the decision-making process. Practitioners described educating patients on the lack of survival benefit and in general discouraging CPM. Practitioners agreed that most patients demonstrate decisional conflict (11/16) as a barrier to decision-making, and it is a challenge to realign patients’ understanding and expectations. Almost all practitioners (15/16) identified a need for information materials to help educate patients on the risks and benefits of CPM and to help realign expectations.


Practitioners have identified CPM in average-risk women with unilateral BC as a patient-driven phenomenon that is on the rise, despite highlighting the increased risk of complications and lack of survival benefit. Our practitioner needs assessment identifies the need for a dynamic decision aid to help guide the shared decision-making process for practitioners and patients.



This study was funded by a grant from CancerCare Ontario and the Ontario Institute for Cancer Research.


None declared.

Supplementary material

10434_2019_7432_MOESM1_ESM.docx (25 kb)
Supplementary material 1 (DOCX 24 kb)


  1. 1.
    Healey EA, Cook EF, Orav EJ, Schnitt SJ, Connolly JL, Harris JR. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993;11(8):1545–52.CrossRefPubMedGoogle Scholar
  2. 2.
    Kollias J, Ellis IO, Elston CW, Blamey RW. Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol. 1999;25(6):584–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Dragun AE, Pan J, Riley EC, Kruse B, Wilson MR, Rai S, Dharamvir J. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Am J Clin Oncol. 2013;36(4):375–80.CrossRefPubMedGoogle Scholar
  4. 4.
    Jones NB, Wilson J, Kotur L, Stephens J, Farrar WB, Agnese DM. Contralateral prophylactic mastectomy for unilateral breast cancer: an increasing trend at a single institution. Ann Surg Oncol. 2009;16:2691–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Guilfoyle C, Christoudias M, Collett AE, Gracely EJ, Frazier TG, Barrio AV. Effect of preoperative MRI on mastectomy and contralateral prophylactic mastectomy rates at a community hospital by a single surgeon. Breast J. 2014;20(1):79–83.CrossRefPubMedGoogle Scholar
  6. 6.
    King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, Morrow M. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29(16):2158–64.CrossRefPubMedGoogle Scholar
  7. 7.
    Rosenberg S, Michaela T, Meyer M, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013;159(6):373–81.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Carbine NE, Lostumbo L, Wallace J, Ko H. Risk-reducing mastectomy for the prevention of primary breast cancer. Cochrane Database Syst Rev. 2018;4:CD002748.Google Scholar
  9. 9.
    Chung A, Huynh K, Lawrence C, Sim MS, Giuliano A. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients. Ann Surg Oncol. 2012;19(8):2600–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Geiger AM, West CN, Nekhlyudov L, et al. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol. 2006;24(9):1350–6.CrossRefPubMedGoogle Scholar
  11. 11.
    Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy consensus statement from the American Society of Breast Surgeons: additional considerations and a framework for shared decision making. Ann Surg Oncol. 2016;23:3106–11.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Boughey JC, Attai DJ, Chen SL, et al. Contralateral prophylactic mastectomy (CPM) consensus statement from the American Society of Breast Surgeons: Data on CPM outcomes and risks. Ann Surg Oncol. 2016;23:3100–5.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Ottawa Hospital Research Institute (2013). Ottawa Decision Support Framework. Available at: Accessed 23 Jun 2018.
  14. 14.
    Parker PA, Peterson SK, Bedrosian I, et al. Prospective study of surgical decision-making processes for contralateral prophylactic mastectomy in women with breast cancer. Ann Surg. 2016;263(1):178–83.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Venetis MK, MacGeorge EL, Baptiste DF, et al. Social network, surgeon, and media influence on the decision to undergo contralateral prophylactic mastectomy. Am J Clin Oncol. 2018;41:519–25.CrossRefPubMedGoogle Scholar
  16. 16.
    Jagsi R, Hawley ST, Griffith KA, et al. Contralateral prophylactic mastectomy decisions in a population-based sample of patients with early-stage breast cancer. JAMA Surg. 2017;152(3):274–82.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T. Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol. 2011;18:3129–36.CrossRefPubMedGoogle Scholar
  18. 18.
    Bellavance E, Peppercorn J, Kronsberg S, et al. Surgeons’ perspectives of contralateral prophylactic mastectomy. Ann Surg Oncol. 2016;23:2779–87.CrossRefPubMedGoogle Scholar
  19. 19.
    Gao X, Fisher S, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56(4):1038–45.CrossRefPubMedGoogle Scholar
  20. 20.
    Covelli AM, Baxter NN, Fitch MI, McCready DR, Wright FC. Taking control of cancer: understanding women’s choice for mastectomy. Ann Surg Oncol. 2015;22:383–91.CrossRefPubMedGoogle Scholar
  21. 21.
    Musiello T, Bornhammar E, Saunders C. Breast surgeons’ perceptions and attitudes towards contralateral prophylactic mastectomy. ANZ J Surg. 2013;83:527–532.CrossRefPubMedGoogle Scholar
  22. 22.
    Arrington AK, Jarosek SL, Virnig BA, Habermann EB, Tuttle TM. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol. 2009;16:2697–704.CrossRefPubMedGoogle Scholar
  23. 23.
    Agarwal S, Kidwell KM, Kraft CT, Kozlow JH, Sabel MS, Chung KC, Momoh AO. Defining the relationship between patient decisions to undergo breast reconstruction and contralateral prophylactic mastectomy. Plast Reconstr Surg. 2015;135:661–70.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Ashfaq A, McGhan LJ, Pockaj BA, et al. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy. Ann Surg Oncol. 2014;21:2934–40.CrossRefPubMedGoogle Scholar
  25. 25.
    Boughey JC, Schilz SR, Van Houten HK, Zhu L, Habermann EB, Lemaine V. Contralateral prophylactic mastectomy with immediate breast reconstruction increases healthcare utilization and cost. Ann Surg Oncol. 2017;24(10):2957–64.CrossRefPubMedGoogle Scholar
  26. 26.
    Billig JI, Duncan A, Zhong L, et al. The cost of contralateral prophylactic mastectomy in women with unilateral breast cancer. Plast Reconstr Surg. 2018;141(5):1094–102.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Miller ME, Czechura T, Martz B, et al. Operative risks associated with contralateral prophylactic mastectomy: a single institution experience. Ann Surg Oncol. 2013;20:4113–20.CrossRefPubMedGoogle Scholar
  28. 28.
    Osman F, Saleh F, Jackson TD, Corrigan MA, Cil T. Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database. Ann Surg Oncol. 2013;20:3212–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Fayanju OM, Stoll CRT, Fowler S, Colditz GA, Margenthaler JA. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis. Ann Surg. 2014;260:1000–10.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of SurgerySelkirk Regional Health CentreSelkirkCanada
  2. 2.Department of Health Research Methods, Evidence, and ImpactMcMaster UniversityHamiltonCanada
  3. 3.Department of SurgeryThe Ottawa HospitalOttawaCanada
  4. 4.Department of Surgical OncologySunnybrook Health Sciences CentreTorontoCanada
  5. 5.Department of Medical OncologySunnybrook Health Sciences CentreTorontoCanada
  6. 6.Department of SurgerySt. Michael’s HospitalTorontoCanada
  7. 7.CIBC Breast CentreSt. Michael’s HospitalTorontoCanada

Personalised recommendations